Skip Navigation LinksHome > Current Issue > Contributor Index

May 15, 2015 - Volume 29 - Issue 8 - Contributor Index

View All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Other
Actions
View
Author Name Article
Canetta, Pietro A.

Nonalbumin proteinuria predominates in biopsy-proven tenofovir nephrotoxicity

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Carr, Andrew

Limited reporting of major harms in studies of initial combination antiretroviral therapy: a systematic review

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Carrieri, Maria Patrizia

Securing opioid substitution treatment access and quality for people who inject drugs

Purchase Access
PDF
+ Favorites
Request Permissions
Catalano, Renae

Reduction of soluble CD163, substance P, programmed death 1 and inflammatory markers: phase 1B trial of aprepitant in HIV-1-infected adults

Open Access
Supplemental Author Material
Abstract
PDF
+ Favorites
Request Permissions
Chen, Xiaoli

Role of intestinal myofibroblasts in HIV-associated intestinal collagen deposition and immune reconstitution following combination antiretroviral therapy

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Colley, Guillaume

The causal effect of opioid substitution treatment on HAART medication refill adherence

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Cooke, Graham

Apparent spontaneous clearance of chronic hepatitis C virus infection in a HIV co-infected patient with decompensated cirrhosis: a case report

Open Access
PDF
+ Favorites
Request Permissions
Cooper, David A.

Early antiretroviral therapy with raltegravir generates sustained reductions in HIV reservoirs but not lower T-cell activation levels

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Curto, Jordi

Telaprevir decreases estimated glomerular filtration rate in HIV-hepatitis C virus coinfected patients

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Cwynarski, Kate

Adding rituximab to CODOX-M/IVAC chemotherapy in the treatment of HIV-associated Burkitt lymphoma is safe when used with concurrent combination antiretroviral therapy

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Actions
View